View Single Post
Old 11-13-2012, 09:04 PM   #29
seqnextgen
Junior Member
 
Location: USA

Join Date: May 2011
Posts: 7
Default

Quote:
Originally Posted by TonyBrooks View Post
The problem is that scaffold runs for de novo are so niche in the grand scheme of things. The real money will be in resequencing, RNA-Seq, ChIP-Seq etc. As a core group, I'd say 99% of things we get asked to do fall into those categories. There's still a long way to go for ONT until it becomes a viable alternative.
Q14 is only really of value when you have a bunch of short read Q30s you can pin to the scaffold.
Maybe, but once de novo assembly is really available with a reasonable price, I believe it is the way to go. Ever wonder where those "copy number variants" are in a genome. It might be hard to believe that where they are is not important.
seqnextgen is offline   Reply With Quote